Cytochrome P450 and the metabolism and bioactivation of arachidonic acid and eicosanoids

Cytochrome P450: Structure, Mechanism, and Biochemistry: Third edition

Volumn , Issue , 2005, Pages 531-551

  Capdevila, Jorge H ^a   Holla, Vijaykumar R ^b   Falck, John R ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892335196     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-27447-2_11     Document Type: Chapter

References (141)

1. Smith, W. L., D. L. De Witt, and R. M. Garavito (2000). Cyclooxygenases: Structural, cellular, and molecular biology. Ann. Rev. Biochem. 69, 145-182, and cited references.
2. Prescott, S. M. and C. Yang (2002). Many actions of cyclooxygenase-2 in cellular dynamics and in Cancer. J. Cell. Biol. 190, 279-286.
3. Brash, A. R. (1999). Lipoxygenases: Occurrence, function, catalysis, and acquisition substrate. J. Biol. Chem. 274, 23679-23680, and cited references.
4. Capdevila, J. H. and J. R. Falck (2001). The CYP P450 arachidonic acid monooxygenases: From cell signaling to blood pressure regulation. Biochem. Biophys. Res. Comm. 285, 571-576, and cited references.
5. Capdevila, J. H. and J. R. Falck (2002). Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases. Prostaglandins other Lipid Medial. 68-69, 325-344, and cited references.
6. McGiff, J. C. and J. Quilley (1999). 20-HETE and the kidney: Resolution of old problems and new beginnings. Am. J. Physiol. 277, R607-R623, and cited references.
7. McGiff, J. C. and J. Quilley (2001). 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr. Opin. Nephrol. Hypertens. 10, 31-237, and cited references.
8. Imig, J. D. (2000). Eicosanoid regulation of renal vasculature. Am. J. Physiol. 279, F965-F981, and cited references.
9. Campbell, W. B. and D. R. Harder (1999). Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circ. Res. 84, 484-488, and cited references.
10. Roman, R. J. (2002). P450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 82, 131-185, and cited references.
11. Capdevila, J. H., N. Chacos, J. Werringloer, R. A. Prough, and R. W. Estabrook (1981). Liver microsomal cytochrome P-450 and the oxidative metabolism of AA. Proc. Natl. Acad. Sci. USA 78, 5362-5366.
12. Morrison, A. R. and N. Pascoe (1981). Metabolism of AA through NADPH-dependent oxygenase of renal cortex. Proc. Natl. Acad. Sci. USA 78, 7375-7378.
13. Oliw, E. H. and J. A. Oates (1981). Oxygenation of AA by hepatic microsomes of the rabbit. Mechanism of biosynthesis of two vicinal diols. Biochim. Biophys. Acta 666, 327-340.
14. Jacobson, H. R., S. Corona, J. H. Capdevila, N. Chacos, S. Manna, A. Womack et al. (1984). Effects of epoxyeicosatrienoic acids on ion transport in the rabbit cortical collecting tubule. In P. Braquet, J. C. Frolich, S. Nicosia, and R. Garay (eds), Prostaglandins and Membrane Ion Transport. Raven Press, New York, p. 311.
15. Karara, A., E. Dishman, I. Blair, J. R. Falck, and J. H. Capdevila (1989). Endogenous epoxyeicosatrienoic acids. Cytochrome P-450 controlled stereoselectivity of the hepatic arachidonic acid epoxygenase. J. Biol. Chem. 264, 19822-19827.
16. Kupfer, D. (1982). Endogenous substrates of monooxygenases: Fatty acids and prostaglandins. In J. B. Schenkman and D. Kupfer (eds), Hepatic Cytochrome P-450 Monooxygenase System. Pergamon Press, New York, pp. 157-187.
17. Sharma, R. K., M. V. Doig, D. F. V. Lewis, and G. Gibson (1989). Role of hepatic and renal cytochrome P450 IVA1 in the metabolism of lipid substrates. Biochem. Pharmacol. 38, 3621-3629.
18. Imaoka, S., S. Tanaka, and Y. Funae (1989). (ω/ω-1) hydroxylation of lauric acid and arachidonic acid by rat renal cytochrome P-450. Biochem. Int. 18, 731-740.
19. Johnson, E. F., D. L. Walker, and K. J. Griffin (1990). Cloning and expression of three rabbit kidney cDNAs encoding lauric acid-hydroxylases. Biochemistry 29, 873-879.
20. Kikuta, Y., E. Kusunose, and M. Kusunose (2002). Prostaglandin and leukotriene ω-hydroxylases. Prostaglandins other Lipid Medial. 68-69, 325-344, and cited references.
21. Rahimtula, A. D. and P. J. O'Brien (1974). Hydroperoxide catalyzed liver microsomal aromatic hydroxylation reactions involving cytochrome P-450. Biochem. Biophys. Res. Commun. 60, 440-447.
22. Weiss, R. H, J. L. Arnold, and R. W. Estabrook (1987). Transformation of an arachidonic acid hydroperoxide into epoxyhydroxy and trihydroxy fatty acids by liver microsomal cytochrome P-450. Arch. Biochem. Biophys. 252, 334-338.
23. 2 biosynthesis. J. Biol. Chem. 264, 141-150.
24. Hara, S., A. Miyata, C. Yokoyama, R. Brugger, F. Lottspeich, V. Ullrich et al. (1995). Molecular cloning and expression of prostacyclin synthase from endothelial cells. Adv. Prostaglandin Thromboxane Leukot. Res. 23, 121-123.
25. Yokoyama, C., A. Miyata, H. Ihara, V. Ullrich, and T. Tanabe (1991). Molecular cloning of the human platelet thromboxane A synthase. Biochem. Biophys. Res. Commun. 178, 1479-1484.
26. Ohashi, K., K. H. Ruan, R. J. Kulmacz, K. K. Wu, and L. H. Wang (1992). Primary structure of human thromboxane synthase determined from the cDNA sequence. J. Biol. Chem. 267, 789-793
27. White, R. E. and M. G. Coon (1980). Oxygen activation by cytochrome P-450. Ann. Rev. Biochem. 49, 315-356, and references therein.
28. Wong, P. Y. K., K. U. Malik, B. M. Taylor, W. P. Schneider, J. C. McGiff, and F. F. Sun (1985). Epoxidation of prostacyclin in the rabbit kidney. J. Biol. Chem. 260, 9150-9153.
29. 1 metabolites. Biochim. Biophys. Acta. 793, 408-415.
30. Zhang, J. Y., C. Prakash, K. Yamashita, and I. A. Blair (1992). Regiospecific and enantioselective metabolism of 8, 9-epoxyeicosatrienoic acids by cyclooxygenase. Biochem. Biophys. Res. Commun. 183, 138-143.
31. Jajoo, H. K., J. H. Capdevila, J. R. Falck, R. K. Bhatt, and I. A. Blair (1992). Metabolism of 12 (R)-hydroxyeicosatetraenoic acid by rat liver microsomes. Biochim. Biophys. Acta 1123, 110-116.
32. Capdevila, J., P. Mosset, P. Yadagiri, Sun Lumin, and J. R. Falck (1988). NADPH-Dependent microsomal metabolism of 14, 15-epoxyeicosatrienoic acid to diepoxides and epoxyalcohols. Arch. Biochem. Biophys. 261, 122-132.
33. Cowart, L. A., S. Wei, M.-S. Hsu, E. F. Johnson, M. U. Krishna, J. R. Falck et al. (2002). The CYP 4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands. J. Biol. Chem. 277, 35105-35112.
34. Hamberg, M. and B. Samuelsson (1966). Prostaglandins in human seminal plasma. Prostaglandins and related factors. J. Biol. Chem. 241, 257-263.
35. 1. Eur. J. Biochem. 11, 390-394.
36. Kupfer, D., I. Jansson, L. V. Favreau, A. D. Theoharides, and J. B. Schenkman (1988). Regioselective hydroxylation of prostaglandins by constitutive forms of cytochrome P-450 from rat liver: Formation of a novel metabolite by a female-specific P-450. Arch. Biochem. Biophys. 262, 186-195.
37. p-2). J. Biol. Chem. 62, 13366-13371.
38. Sharma, R. K., M. V. Doig, D. F. V. Lewis, and G. Gibson (1989). Role of hepatic and renal cytochrome P450 1VA1 in the metabolism of lipid substrates. Biochem. Pharmacol. 38, 3621-3629.
39. Yokotani, N., R. Bernhardt, K. Sogawa, E. Kusunose, O. Gotoh, M. Kusunose et al. (1989). Two forms of ω-hydroxylase toward prostaglandin A and laurate. cDNA cloning and their expression. J. Biol. Chem. 264, 21665-21669.
40. Kusonuse, E., A. Sawamura, H. Kawashima, I. Kubota, and M. Kusunose (1989). Isolation of a new form of cytochrome P450 with prostaglandin A and fatty acid ω-hydroxylase activities from rabbit kidney cortex microsomes. J. Biochem. 106, 194-206.
41. Kikuta, Y., E. Kusunose, T. Okumoto, I. Kubota, and M. Kusunose (1990). Purification and partial characterization of two forms of cytochrome P450 with ω-hydroxylase activity towards prostaglandin A and fatty acids from rat liver microsomes. J. Biochem. 107, 280-286
42. Roman, L. J., C. A. N. Palmer, J. E. Clark, A. S. Muerhoff, K. J. Griffin, E. F. Johnson et al. (1993). Expression of rabbit cytochrome P4504A which catalyzes the ω-hydroxylation of fatty acids, and prostaglandins. Arch. Biochem. Biophys. 307, 57-67.
43. Bylund, J., M. Hidestrand, M. Ingelman-Sundberg, and E. H. Oliw (2000). Identification of CYP4F8 in human seminal vesicles as a prominent 19-hydroxylase of prostaglandin endoperoxides. J. Biol. Chem. 275, 21844-21849.
44. Lasker, J. M., B. W. Chen, I. Wolf, B. P. Blswck, P. D. Wilson, and P. K. Powell (2000). Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid in human kidney. J. Biol. Chem. 264, 17845-17853.
45. An updated list of P450 genes and sequences is found at: http://drnelson. utmem.edu/CytochromeP450.html
46. Imaoka, S., H. Ogawa, S. Kimura, and F. J. Gonzalez (1993). Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid omega-hydroxylase expressed in human kidney. DNA Cell Biol. 12, 893-899.
47. Kawashima, H., T. Naganuma, E. Kusunose, T. Kono, R. Yasumoto, K. Sugimura et al. (2000). Human fatty acid w-hydroxylase, CYP 4A11: Determination of complete genomic sequence and characterization of purified recombinant protein. Arch. Biochem. Biophys. 378, 333-339.
48. Bellamine, A., Y. Wang, M. R. Waterman, J. V. Gainer, E. Dawson, N. J. Brown et al. (2003). Characterization of the CYP4A11 gene, a second CYP4A gene in humans. Arch. Biochem. Biophys. 409, 221-227.
49. Wang, M. H., D. E. Stec, M. Balazy, V. Mastyugin, C. S. Yang, R. J. Roman et al. (1997). Cloning, sequencing, and cDNA-directed expression of rat renal CYP4A2: AA ω-hydroxylation and 11, 12-epoxidation by CYP4A2 protein. Arch. Biochem. Biophys. 336, 240-250.
50. Helvig, C, E. Dishman, and J. H. Capdevila (1998). Molecular, enzymatic, and regulatory characterization of rat kidney cytochromes P450 4A2 and 4A3. Biochemistry 37, 12546-12558.
51. Hoch, U, Z. Zhang, D. L. Kroetz, and P. R. Ortiz De Montellano (2000). Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega hydroxylases. Arch. Biochem. Biophys. 373, 63-71.
52. Nishimoto, M, J. E. Clark, and B. S. S. Masters (1993). Cytochrome P450 4A4: Expression in Escherichia coli, purification, and characterization of catalytic properties. Biochemistry 32, 8863-8870.
53. Bylund, J., M. Bylund, and E. H. Oliw (2001). cDNA cloning and expression of CYP4F12, a novel human cytochrome P450. Biochem. Biophys. Res. Commun. 280, 892-897.
54. 4: Metabolism and signal transduction. Arch. Biochem. Biophys. 385, 231-241, and cited references.
55. Haeggstrom, J. Z. and A. Wetterholm (2002). Enzymes and receptors in the leukotriene cascade. Cell. Mol. Life Sci. 59, 742-753, and cited references.
56. 4 20-hydroxylase from polymorphonuclear leukocytes. J. Biol. Chem. 259, 3082-3089.
57. 4 in human polymorphonuclear leukocytes. J. Biol. Chem. 259, 10181-10187.
58. 4 hydroxylases. J. Biol. Chem. 262, 1590-1595.
59. 4 20-hydroxylase. J. Biol. Chem. 262, 12421.
60. Sumimoto, J., K. Takeshige, and S. Minakami (1988). Characterization of human neutrophil leukotriene B4 omega-hydroxylase, a system involving a unique cytochrome P-450 and NADPH-cytochrome P-450 reductase. Eur. J. Biochem. 172, 315-324.
61. 4 ω-hydroxylase. J. Biol. Chem. 268, 9376-9380.
62. 4 ω-hydroxylase (Cytochrome 4F3). Arch. Biochem. Biophys. 355, 201-205.
63. 4 ω-hydroxylase. J. Biol. Chem. 274, 21191-21199.
64. Kikuta, Y, E. Kusunose, M. Ito, and M. Kusunose (1999). Purification and characterization of recombinant rat hepatic 4F1. Arch. Biochem. Biophys. 369, 193-196.
65. 4. Arch. Biochem. Biophys. 359, 89-98.
66. Kawashima, H., E. Kusunose, C. M. Thompson, and H. W. Strobel (1997). Protein expression, characterization, and regulation of CYP4F4 and CYP4F5 cloned from rat brain. Arch. Biochem. Biophys. 347, 148-154.
67. Wong, P. Y. K., P. Westlund, M. Hamberg, E. Granstrom, P. W. H. Chao, and B. Samuelsson (1984). ω-Hydroxylation of 12-L-hydroxy-5, 8, 10, 14-eicosatetraenoic acid in human polymorphonuclear leukocytes. J. Biol. Chem. 259, 2683-2686.
68. Marcus, A. J., L. B. Safier, H. L. Ullman, N. Broekman, T. Islam, D. Oglesby et al. (1984). 125, 20-Dihydroxyeicosatetraenoic acid: A new icosanoid synthesized by neutrophils from 12S-hydroxyeicosatetraenoic acid produced by thrombin- or collagen-stimulated platelets. Proc. Natl. Acad. Sci. USA 81, 903-907.
69. 2+ and protein kinase C mobilization in neutrophils. Biochem. Biophys. Res. Commun. 148, 575-579.
70. Okita, R. T., R. J. Soberman, J. M. Bergholte, B. S. S. Masters, R. Hayes, and R. C. Murphy (1987). ω-Hydroxylation of 15- hydroxyeicosatetraenoic acid by lung microsomes from pregnant rabbits. Mol. Pharmacol. 32, 706-709.
71. Capdevila, J. H., A. Karara, D. J. Waxman, M. V. Martin, J. R. Falck, and F. P. Guengerich (1990). Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal AA epoxygenase. J. Biol. Chem. 265, 10865-10871.
72. Knickle, L. C. and J. R. Bend (1994). Bioactivation of arachidonic acid by the cytochrome P450 monooxygense of guinea pig lung: The orthologue of cytochrome P450 2B4 is solely responsible for the formation of epoxyeicosatrienoic acids. Mol. Pharmacol. 45, 1273-1280.
73. Laethem, R. M., J. R. Halpert, and D. R. Koop (1994). Epoxidation of arachidonic acid as an active site probe of cytochrome P450 2B isoforms. Biochim. Biophys. Acta 1206, 42-48.
74. Keeney, D. S., C. Skinner, S. Wei, T. Friedberg, and M. R. Waterman (1998). A keratinocyte-specific epoxygenase, CYP2B12, metabolizes arachidonic acid with unusual selectivity, producing a single major epoxyeicosatrienoic acid. J. Biol. Chem. 273, 9279-9284.
75. Keeney, D. S., C. Skinner, J. B. Travers, J. H. Capdevila, J. B. Nanney, L. E. King et al. (1998). Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2B19, having arachidonate monooxygenase activity. J. Biol. Chem. 273, 32071-32079.
76. Capdevila, J. H., S. Wei, Y. Yan, A. Karara, H. R. Jacobson, J. R. Falck et al. (1992). Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J. Biol. Chem. 267, 21720-21726.
77. Karara, A., K. Makita, H. R. Jacobson, J. R. Falck, F. P. Guengerich, R. N. Du Bois et al. (1993). Molecular cloning, expression, and enzymatic characterization of the rat kidney cytochrome P-450 arachidonic acid epoxygenase. J. Biol. Chem. 268, 13565-13570.
78. Imaoka, S., P. J. Zwedlung, H. Ogawa, S. Kimura, F. J. Gonzalez, and H. Y. Kim (1993). Identification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase. J. Pharmacol. Exp. Ther. 267, 1012-1016.
79. Daikh, B. E., R. M. Laethem, and D. Koop (1994). Stereoselective epoxidation of arachidonic acid by cytochrome P-450s 2CAA and 2C2. J. Pharmacol. Exp. Ther. 269, 1130-1135.
80. Rifkind, A. B., C. Lee, T. K. Chang, and D. J. Waxman (1995). Arachidonic acid metabolisms by human cytochrome P450s 2C 8, 2C 9, 2EI, and 1A2: Regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch. Biochem. Biophys. 320, 380-389.
81. Zeldin, D. C., R. N. Du Bois, J. R. Falck, and J. H. Capdevila (1995). Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Arch. Biochem. Biophys. 322, 76-86.
82. Luo, G., D. C. Zeldin, J. A. Blaisdell, E. Hodgson, and J. A. Goldstein (1998). Cloning, and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. Arch. Biochem. Biophys. 357, 45-57.
83. Tsao, C. C., S. J. Coulter, A. Chien, G. Luo, N. P. Clayton, R. Maronpot et al. (2001). Identification and localization of five CYP2Cs in murine extrahepatic tissues and their metabolism of arachidonic acid to regio- and stereoselective products. J. Pharmacol. Exp. Ther. 299, 39-47.
84. Thompson, CM., J. H. Capdevila, and H. W. Strobel (2000). Recombinant cytochrome P450 2D18 metabolism of dopamine and arachidonic acid. J. Pharmacol. Exp. Ther. 294, 1120-1130.
85. Laethem, R. M., M. Balazy, J. R. Falck, C. L. Laethem, and D. R. Koop (1993). Formation of 19 (S)-, 19 (R)-, and 18 (R)-hydroxyeicosatetraenoic acids by alcoholinducible cytochrome P450 2E1. J. Biol. Chem. 268, 12912-12918.
86. Scarborough, P. E., J. Ma, W. Qy, and D. C. Zeldin (1999). P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues. Drug Metab. Rev. 31, 205-234, and cited references.
87. Zeldin, D. C. (2001). Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem. 276, 36059-36062, and cited references.
88. Oliw, E. H. (1993). Ms-Allylic hydroxylation of linoleic acid and AA by human hepatic monooxygenases. Biochim. Biophys. Acta 1166, 258-263.
89. Brash, A. R., W. E. Boeglin, J. H. Capdevila, S. Yeola, and I. A. Blair (1995). 7-HETE, 10-HETE, and 13-HETE are major products of NADPH-dependent AA metabolism in rat liver microsomes: Analysis of their stereochemistry, and the stereochemistry of their acid-catalyzed rearrangement. Arch. Biochem. Biophys. 321, 485-492.
90. Capdevila, J. H., P. Yadagiri, S. Manna, and J. R. Falck (1986). Absolute configuration of the hydroxyeicosatetraenoic acids (HETEs) formed during catalytic oxygenation of AA by microsomal cytochrome P-450. Biochem. Biophys. Res. Commun. 141, 1007-1011.
91. Woollard, P. M. (1986). Stereochemical differences between 12-hydroxy-5, 8, 10, 14-eicosatetraenoic acid in platelets and psoriatic lesions. Biochem. Biophys. Res. Commun. 136, 169-176.
92. Boeglin, W. E., R. B. Kim, and A. R. Brash (1998). A 12R-lipoxygenase in human skin: Mechanistic evidence, molecular cloning, and expression. Proc. Natl. Acad. Sci. USA 95, 6744-6749.
93. Sun D., M. McDonnel, X. S. Chen, M. M. Lakkis, S. N. Isaacs, S. H. Elsea et al. (1998). Human 12 (R) - lipoxygenase and the mouse ortholog. Molecular cloning, expression, and gene chromosomal assignment. J. Biol. Chem. 273, 33540-33547.
94. +- ATPase in the cornea. Proc. Natl. Acad. Sci. USA 84, 8125-8129.
95. Oliw, E. H. (1993). Biosynthesis of 12 (S)-hydroxyeicosatetraenoic acid by bovine corneal epithelium. Acta Physiol. Scand. 147, 117-121.
96. Murphy, R. C, J. R. Falck, S. Lumin, P. Yadagiri, J. A. Zirrolli, M. Balazy et al. (1988). 12 (R) - Hydroxyeicosatrienoic acid: A vasodilator cytochrome P-450-dependent arachidonate metabolite from bovine corneal epithelium. J. Biol. Chem. 263, 17197-17202.
97. Lu, A. Y., H. K. Junk, and M. J. Coon (1969). Resolution of the cytochrome P-450 containing ω-hydroxylation system of liver microsomes into three components. J. Biol. Chem. 244, 3714-3721.
98. Capdevila, J. H., S. Wei, C. Helvig, J. R. Falck, Y. Belosludtsev, G. Truan et al. (1996). The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3. J. Biol. Chem. 271, 22663-22671
99. Graham-Lorence, S., G. Truan, J. A. Peterson, J. R. Falck, S. Wei, and C. Helvig et al. (1997). An active site substitution, F87V, converts cytochrome P450 BM3 into a regio- and stereoselective (14) S, 15 (R)-AA epoxygenase. J. Biol. Chem. 272, 1127-1135.
100. Holla, V. R., F. Adas, J. D. Imig, X. Zhao, E. Price, N. Olsen et al. (2001). Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. Proc. Natl. Acad. Sci. USA 98, 5211-5216.
101. Henderson, C. J., A. R. Scott, C. S. Yang, and C. R. Wolf (1990). Testosterone-mediated regulation of mouse renal cytochrome P-450 isoenzymes. Biochem. J. 266, 675-681.
102. Lund, X, P. G. Zaphiropoulos, A. Mode, M. Warner, and J. A. Gustafsson (1991). Hormonal regulation of cytochrome P450 gene expression. Adv. in Pharmacol. 22, 325-354, and cited references.
103. Henderson, C. J. and C. R. Wolf (1991). Evidence that the androgen receptor mediates sexual differentiation of mouse renal cytochrome P450 expression. Biochem. J. 278, 499-503.
104. Sundseth, S. S. and D. J. Waxman (1992). Sexdependent expression and clofibrate inducibility of cytochrome P450 AA fatty acid ω-hydroxylases. J. Biol. Chem. 267(6), 3915-3921.
105. Lee, S. S., T. Pineau, J. Frago, E. J. Lee, J. W. Owens, D. L. Kroetz et al. (1995). Targeted disruption of the α isoform of the peroxisome proliferatoractivated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisomal proliferators. Mol. Cell. Biol. 15, 3012-3022.
106. Waxman, D. J. and T. K. H. Chang (1995). Hormonal regulation of liver cytochrome P450 enzymes. In PR. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd edn. Plenum Press, New York, pp. 391-418.
107. Waxman, D. J. (1999). P450 gene induction by structurally diverse xenochemicals: Central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys. 369, 11-23.
108. Savas, U., M-H. Hsu, and E. F. Johnson (2003). Differential regulation of human CYP4A genes by peroxisome proliferators and dexamethasone. Arch. Biochem. Biophys. 409, 212-220.
109. Stromsteadt, M., S. Hayashi, P. G. Zaphiropoulos, and J. A. Gustafsson (1990). Cloning and characterization of a novel member of the cytochrome P450 subfamily IVA in rat prostate. DNA Cell Biol. 8, 569-577.
110. Heng, Y. M., C. S. Kuo, P. S. Jones, R. Savory, R. M. Schultz, S. R. Tomlinson et al. (1997). A novel murine P-450 gene, Cyp4al4, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans. Biochem. J. 325, 741-749.
111. Falck, J. R., S. Lumin, I. A. Blair, E. Dishman, M. V. Martin, D. J. Waxman et al. (1990). Cytochrome P-450-dependent oxidation of arachidonic acid to 16-, 17-, and 18-hydroxyeicosatetraenoic acids. J. Biol. Chem. 265, 10244-10249.
112. Rifkind, A. B., A. Kanetoshi, J. Orlinick, J. H. Capdevila, and C. Lee (1994). Purification and biochemical characterization of two major cytochrome P-450 isoforms induced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in chick embryo liver. J. Biol. Chem. 269, 3387-3396.
113. Qu, W, J. A. Bradbury, C-C. Tsao, R. Maronpot, G. J. Harry, C. E. Parker et al. (2001). Cytochrome P450 CYP2J9, a new mouse arachidonic acid ω-1 hydroxylase predominantly expressed in brain. J. Biol. Chem. 276(27), 25467-25479.
114. Marji, J. S., M. H. Wang, and M. Laniado-Schwartzman (2002). Cytochrome P-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries. Am. J. Physiol. 283, F60-F67.
115. Hashimoto, T., T. Fujita, N. Usuda, W. Cook, C. Qi, J. M. Peters et al. (1999). Peroxisomal and mitochondrial fatty acid oxidation in mice nullizygous for both peroxisome proliferator-activated receptor and peroxisomal fatty acyl-CoA oxidase. Genotype correlate with fatty liver phenotype. J. Biol. Chem. 274, 19228-19236.
116. Chacos, N., J. F. Falck, C. Wixtrom, and J. Capdevila (1982). Novel epoxides formed during the liver cytochrome P-450 oxidation of AA. Biochem. Biophys. Res. Commun. 104, 916-922.
117. Karara, A., E. Dishman, Jr. Falck, and J. H. Capdevila (1991). Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties. J. Biol. Chem. 266, 7561-7569.
118. Fang, X., T. L. Kaduce, M. Van Rollins, N. L. Weintraub, and A. A. Spector (2000). Conversion of epoxyeicosatrienoic acids (EETs) to chain-shortened epoxy fatty acids by human skin fibroblasts. J. Lipid Res. 41, 66-74.
119. Zeldin, D. C., J. Kobayashi, J. R. Falck, B. S. Winder, B. D. Hammock, J. R. Snapper et al. (1993). Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J. Biol. Chem. 268, 6402-6407.
120. Spearman, M. E., R. A. Prough, R. W. Estabrook, J. R. Falck, S. Manna, K. C. Leibman et al. (1985). Novel glutathione conjugates formed from epoxyeicosatrienoic acids (EETs). Arch. Biochem. Biophys. 242, 225-230.
121. Yu, Z., F. Xu, L. M. Huse, C. Morisseau, A. J. Draper, J. W. Newman et al. (2000). Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ. Res. 87, 992-998.
122. Sinal, C. J., M. Miyata, M. Tohkin, K. Nagata, J. R. Bend, and F. J. Gonazalez (2000). Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J. Biol. Chem. 275, 40504-40510.
123. Holla, V., K. Makita, P. G. Zaphiropoulos, and J. H. Capdevila (1999). The kidney cytochrome P450 2C23 AA epoxygenase is upregulated during dietary salt loading. J. Clin. Invest. 104, 751-760
124. Rifkind, A. B., A. Kanetoshi, J. Orlinick, J. H. Capdevila, and C. Lee (1994). Purification and biochemical characterization of two major cytochrome P-450 isoforms induced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in chick embryo liver. J. Biol. Chem. 269, 3387-3396.
125. Campbell, W. B., D. Gebremedhin, P. F. Pratt, and D. R. Harder (1996). Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Cir. Res. 78, 415-423.
126. Fisslthaler, B., R. Popp, L. Kiss, M. Potente, D. R. Harder, I. Fleming et al. (1999). Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 410, 493-497.
127. Imig, J. D., J. R. Falck, S. Wei, and J. H. Capdevila (2001). Epoxygenase metabolites contribute to nitric oxide-independent afferent arteriolar vasodilation in response to bradykinin. J. Vasc. Res. 38, 247-255.
128. Imig, ID., X. Zhao, J. R. Falck, S. Wei, and J. H. Capdevila (2001). Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11, 12-epoxyeicosatrienoic acid. J. Hypertension 19, 983-992.
129. Karara, A., S. Wei, S. D. Spady, L. Swift, J. H. Capdevila, and J. R. Falck (1992). Arachidonic acid epoxygenase: Structural characterization and quantification of epoxyeicosatrienoates in plasma. Biochem. Biophys. Res. Commun. 182, 1320-1325.
130. Capdevila, J. H., Y. Jin, A. Karara, and J. R. Falck (1993). Cytochrome P450 epoxygenase dependent formation of novel endogenous epoxyeicosatrienoyl- phospholipids. In S. Nigam, L. J. Marnett, K. V Honn, and T. L. Walden Jr. (eds), Eicosanoids and Other Bioactive Lipids in Cancer, Inflamation and Radiation Injury. Kluwer Academic Publishers, Boston, MA, pp. 11-15.
131. + channel in renal arterioles. Am. J. Physiol. 270, R228-R237.
132. Su, P., K. M. Kaushal, and D. L. Kroetz (1998). Inhibition of renal arachidonic acid omegahydroxylase activity with ABT reduces blood pressure in the SHR. Am. J. Physiol. 275, R426-R438.
133. Wang, M. H., F. Zhang, J. Marji, B. A. Zand, A. Nasjletti, and M. Laniado-Schwartzman (2001). CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR. Am. J. Physiol. 280, 255-261.
134. Ma, Y. H., M. L. Schwartzman, and R. J. Roman (1994). Altered renal P-450 metabolism of arachidonic acid in dahl salt-sensitive rats. Am. J. Physiol. 267, R579-R589.
135. Zhou, A. P., H. A. Drummond, and R. J. Roman (1996). Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr. rats. Hypertension 27, 631-635.
136. Makita, K., K. Takahashi, A. Karara, H. R. Jacobson, J. R. Falck, and J. H. Capdevila (1994). Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J. Clin. Invest. 94, 2414-2420.
137. Nakagawa, K., J. S. Marji, M. L. Schwartzman, M. R. Waterman, and J. H. Capdevila (2003). The androgen-mediated induction of kidney arachidonate hydroxylases is associated with the development of hypertension. Am. J. Physiol. 284, R1055-R1062.
138. Kroetz, D. L., P. Yook, P. Costet, P. Bianchi, and T. Pineau (1998). Peroxisome proliferatoractivated receptor α controls the hepatic CYP4A induction adaptative response to starvation and diabetes. J. Biol. Chem. 273, 31581-31589.
139. Corton, J. C., L-Q. Fan, S. Brown, S. P. Anderson, C. Bocos, and R. C. Cattley et al. (1998). Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisomal proliferator chemicals. Mol. Pharmacol. 54, 463-473.
140. Shatara, R. K., D. W. Quest, and T. W. Wilson (2000). Fenofibrate lowers blood pressure in two genetic models of hypertension. Can. J. Physiol. Pharmacol. 78, 367-371.
141. Roman, R. J., Y. H. Ma, B. Frohlich, and B. Markham (1993). Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats. Hypertension 21, 985-988.